Table 2.
Clinical Impact (Admission Periods)
| Characteristic | Control Group (n = 512) | ECIL-4 Group (n = 446) | P Value |
|---|---|---|---|
| Febrile neutropenia | 441 (86.1) | 406 (91.0) | .020 |
| No. of fever episodes, median (range) | 1 (0–4) | 1 (0–4) | <.001 |
| 0 | 71 (13.9) | 40 (9.0) | |
| 1 | 250 (48.8) | 193 (43.3) | |
| 2 | 156 (30.5) | 145 (32.5) | |
| 3 | 31 (6.1) | 60 (13.5) | |
| 4 | 4 (0.8) | 8 (1.8) | |
| Bacteremia | 156 (30.5) | 209 (46.9) | <.001 |
| Severe sepsis | 51 (10.0) | 48 (10.8) | |
| Septic shock | 23 (4.5) | 21 (4.7) | |
| Infection-related ICU admission | 21 (4.1) | 22 (4.9) | |
| Mortality during hospitalization | |||
| Overall mortality | 14 (2.7) | 3 (0.7) | .016 |
| Infection-related mortality | 9 (1.8) | 2 (0.4) | .058 |
Data are presented as No. (%) unless otherwise indicated.
Abbreviations: ECIL-4, Fourth European Conference on Infections in Leukaemia; ICU, intensive care unit.